HEIDELBERG PHARMA AG O.N./ DE000A11QVV0 /
06/09/2024 21:39:37 | Chg. -0.0100 | Volume | Bid21:39:37 | Ask21:39:37 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.3900EUR | -0.42% | 1,000 Turnover: 2,490 |
-Bid Size: - | -Ask Size: - | 85.78 mill.EUR | 0.00% | - |
Assets
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1.3000 | 1.9000 | 2.4000 | 3.1000 | 3.7000 | ||||||
Intangible Assets | 2.8000 | 2.8000 | 2.8000 | 2.8000 | 2.9000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 10.3000 | 10.9000 | 11.4000 | 12.1000 | 12.7000 | ||||||
Inventories | .2000 | .2000 | .2000 | .2000 | .7000 | ||||||
Accounts Receivable | .3000 | .4000 | 1.2000 | 1.2000 | 1 | ||||||
Cash and Cash Equivalents | 30.4000 | 19.4000 | 9.9000 | 5 | 6.1000 | ||||||
Current Assets | 31.2000 | 20.3000 | 11.6000 | 7.5000 | 9 | ||||||
Total Assets | 41.5000 | 31.2000 | 23 | 19.6000 | 21.7000 |
Liabilities
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1.5000 | .4000 | 1 | 2.8000 | .9000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 10.5000 | ||||||
Provisions | .4000 | - | - | - | - | ||||||
Liabilities | 4.5000 | 5.3000 | 6.7000 | 6.7000 | 14.9000 | ||||||
Share Capital | 22.4530 | 28.1330 | 28.2090 | 31.0620 | 34.1760 | ||||||
Total Equity | 37 | 25.9000 | 16.3000 | 12.9000 | 6.7000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 41.5000 | 31.2000 | 23 | 19.6000 | 21.7000 |
Income Statement
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.9000 | 3.7000 | 7.3000 | 8.5000 | 1.7000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -10.8000 | -11.7000 | -10.1000 | -18.3000 | -25.6000 | ||||||
Interest Income | -.2000 | - | - | -.0100 | -.5000 | ||||||
Income Before Taxes | -11 | -11.7000 | -10.1000 | -18.4000 | -26.1000 | ||||||
Income Taxes | 0.0000 | 0.0000 | .0050 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -11 | -11.7000 | -10.1000 | -18.4000 | -26.1000 |
Per Share
Cash Flow
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -7.9000 | -9.9000 | -8.6000 | -17.9000 | -26.6000 | ||||||
Cash Flow from Investing Activities | -.4000 | -1 | -1 | -1.3000 | -1.4000 | ||||||
Cash Flow from Financing | 34.2000 | 0.0000 | 0.0000 | 0.0000 | 29.2000 | ||||||
Decrease / Increase in Cash | 25.8000 | -10.9000 | -9.6000 | -4.9000 | 1.2000 | ||||||
Employees | 58 | 62 | 69 | 84 | 96 |